1-20 of 120
Catherine M. Bollard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Dose Escalation and Expansion Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Co-Stimulation for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (ENABLE-1)

Robert Weinkove, Philip George, Robert Fyfe, Aine Hurley, Nathaniel Dasyam, Yasmin Nouri, Tess Ostapowicz, Stefan Mullins, Giulia Giunti, Brittany Lavender, Brigitta Mester, Catherine M. Bollard, Travis Perera, Hayden Jina, Alwyn D'Souza, Le Qin, David S. Ritchie, Chris M.A. Frampton, Rachel Perret, Peng Li, Ian Hermans
Journal: Blood
Blood (2024) 144 (Supplement 1): 2067.
https://doi.org/10.1182/blood-2024-201138
Published: 2024
Journal Articles

MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children’s Oncology Group trial AALL1231

CME Clinical Trials & Observations Brief Report
Robert J. Hayashi, Michelle L. Hermiston, Brent L. Wood, David T. Teachey, Meenakshi Devidas, Zhiguo Chen, Robert D. Annett, Barbara L. Asselin, Keith August, Steve Cho, Kimberly P. Dunsmore, Jason Lawrence Freedman, Paul J. Galardy, Paul Harker-Murray, Terzah M. Horton, Alok Jaju, Allison Lam, Yoav H. Messinger, Rodney R. Miles, Maki Okada, Samir Patel, Eric S. Schafer, Tal Schechter, Kristin A. Shimano, Neelam Singh, Amii Steele, Maria L. Sulis, Sarah L. Vargas, Stuart S. Winter, Charlotte Wood, Patrick A. Zweidler-McKay, Mignon L. Loh, Stephen P. Hunger, Elizabeth A. Raetz, Catherine M. Bollard, Carl E. Allen
Journal: Blood
Blood (2024) 143 (20): 2053–2058.
https://doi.org/10.1182/blood.2023021184
Published: 2024
Includes: Supplemental data
Journal Articles

Reduced Intensity Haploidentical Bone Marrow Transplantation in Adults with Severe Sickle Cell Disease: BMT CTN 1507

Adetola A. Kassim, Mark C. Walters, Mary Eapen, Nicole Ritzau, Madoc Smith, Melhem M. Solh, Christopher McKinney, Michael Nieder, Maureen Ross, Michael Kent, Ghada Abusin, Kanwaldeep K. Mallhi, Jorge Galvez Silva, Paul Shaughnessy, Julie Kanter, Hilary Haines, Rafic J Farah, Yasser Khaled, Allistair Abraham, Catherine M. Bollard, Kenneth R. Cooke, Josu de La Fuente, Rabi Hanna, Mary M. Horowitz, Lori C Jordan, Lakshmanan Krishnamurti, Eric Leifere, Kris Michael Mahadeo, Shalini Shenoy, Nicole M. Ritzau, Michael R. DeBaun, Robert A. Brodsky
Journal: Blood
Blood (2023) 142 (Supplement 2): LBA-4.
https://doi.org/10.1182/blood-2023-192022
Published: 2023
Journal Articles

A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma (Glo-BNHL)

Emma Seaford, Shanna Maycock, Sarah Alexander, Auke Beishuizen, Birte Wistinghausen, Veronique Minard-Colin, Charlotte Rigaud, Charles A Phillips, James B. Ford, Pamela R. Kearns, Anna Lawson, Ellie Williams, Zahra Ahmed, Mahnoor Muzaffar, Rhianna Parsons, Lia Gore, Nicole Scobie, Victoria Buenger, Carl Allen, Karin Mellgren, Catherine M. Bollard, Anne Auperin, Lucinda Billingham, Gladstone Austin Amos Burke
Journal: Blood
Blood (2023) 142 (Supplement 1): 3097.
https://doi.org/10.1182/blood-2023-178658
Published: 2023
Journal Articles

Identifying Tumor-Specific Immune Response and Biomarkers of High-Risk Hodgkin Lymphoma Patients Treated with and without Brentuximab on Children's Oncology Group Trial AHOD1331

Keri Toner, Hema Dave, Gloria Pezzella, Qinglin Pei, Terzah M. Horton, Kara M. Kelly, Lisa Giulino Roth, Sharon M. Castellino, Catherine M. Bollard
Journal: Blood
Blood (2023) 142 (Supplement 1): 4383.
https://doi.org/10.1182/blood-2023-180791
Published: 2023
Journal Articles

A Potential Paradigm for the Robust and Systematic Prioritisation of Assets in Academic-Led, Multi-Industry Collaborative Trials in Rare Populations (Glo-BNHL)

Emma Seaford, Nicole Scobie, Lia Gore, Sarah Alexander, Auke Beishuizen, Birte Wistinghausen, Veronique Minard-Colin, Catherine M. Bollard, Karin Mellgren, Carl Allen, Anne Auperin, Victoria Buenger, Pamela R. Kearns, Anna Lawson, Ellie Williams, Shanna Maycock, Zahra Ahmed, Mahnoor Muzaffar, Rhianna Parsons, Lucinda Billingham, Gladstone Austin Amos Burke
Journal: Blood
Blood (2023) 142 (Supplement 1): 6247.
https://doi.org/10.1182/blood-2023-178724
Published: 2023
Journal Articles

A Phase 1 Dose Escalation Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Intracellular Domains for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (ENABLE)

Robert Weinkove, Philip George, Robert Fyfe, Nathaniel Dasyam, Yasmin Nouri, Tess Ostapowicz, Stefan Mullins, Brigitta Mester, Giulia Giunti, Catherine M. Bollard, Travis Perera, Hayden Jina, Alwyn D'Souza, Le Qin, David S. Ritchie, Chris M.A. Frampton, Rachel Perret, Peng Li, Ian Hermans
Journal: Blood
Blood (2023) 142 (Supplement 1): 890.
https://doi.org/10.1182/blood-2023-178872
Published: 2023
Journal Articles

Correlation of Minimal Residual Disease (MRD) at the End of Induction (EOI) and Event Free Survival (EFS) in T-Cell Lymphoblastic Lymphoma (T-LL), a Report from the Children's Oncology Group (COG) Trial AALL1231

Robert J. Hayashi, Michelle L. Hermiston, David T. Teachey, Meenakshi Devidas, Brent L. Wood, Zhiguo Chen, Robert D Annett, Barbara L Asselin, Keith J August, Steve Y Cho, Kimberly P. Dunsmore, Jason L. Freedman, Paul J. Galardy, Paul Harker-Murray, Terzah M. Horton, Alok I Jaju, Allison Lam, Yoav H. Messinger, Rodney R. Miles, Maki Okada, Samir I Patel, Eric S Schafer, Tal Schechter-Finkelstein, Kristin A. Shimano, Neelam Singh, Amii C. Steele, Maria Luisa Sulis, Sarah L Vargas, Stuart S. Winter, Charlotte Wood, Patrick A Zweidler-McKay, Mignon L. Loh, Stephen P. Hunger, Elizabeth A. Raetz, Catherine M Bollard, Carl Allen
Journal: Blood
Blood (2022) 140 (Supplement 1): 6387–6389.
https://doi.org/10.1182/blood-2022-159694
Published: 2022
Journal Articles

Phase I Study to Improve Anti-Viral Immunity after Cord Blood Transplantation Using Cord-Blood-Derived Multi-Virus-Specific T-Cells

Shweta Bansil, Cecilia Motta, Rachel Dicioccio, Samuel O'Brien, Haili Lang, Michael Keller, Allistair Abraham, David Jacobsohn, Blachy J Davila Saldana, Amanda L. Olson, Elizabeth J Shpall, Indreshpal Kaur, Patrick J Hanley, Catherine M Bollard
Journal: Blood
Blood (2022) 140 (Supplement 1): 10239–10240.
https://doi.org/10.1182/blood-2022-167874
Published: 2022
Journal Articles

Phase I Study Evaluating Outcomes of Autologous HIV-Specific T Cells Targeting Non-Escaped Epitopes (HST-NEET) Therapy in HIV+ Individuals on ART (NCT03485963)

Danielle K. Sohai, Michael Keller, Patrick J. Hanley, Anushree Datar, Emily Reynolds, Dennis Copertino, Chase McCann, Haili Lang, Cecilia Motta, Andrew Wilson, Rebecca Lynch, Winiffer Conce Alberto, Zabrina L. Brumme, Natalie N. Kinloch, Conrad Russell Y. Cruz, Lynsay MacLaren Ehui, Sarah Henn, R. Brad Jones, Catherine M Bollard
Journal: Blood
Blood (2022) 140 (Supplement 1): 7498–7499.
https://doi.org/10.1182/blood-2022-165775
Published: 2022
Journal Articles

Percent Patient NK and T Cells at Day 28 Predict Graft Outcome after Haploidentical Hematopoietic Cell Transplant for Sickle Cell Disease

Mariah Jensen-Wachspress, Haili Lang, Gelina Sani, Deepali K Bhat, Emily Limerick, Xin Xu, Kenneth Fulton, Catherine M Bollard, Courtney D. Fitzhugh, Allistair Abraham
Journal: Blood
Blood (2022) 140 (Supplement 1): 7609–7610.
https://doi.org/10.1182/blood-2022-166878
Published: 2022
Journal Articles

Cellular therapies for the treatment and prevention of SARS-CoV-2 infection

Susan R. Conway, Michael D. Keller, Catherine M. Bollard
Journal: Blood
Blood (2022) 140 (3): 208–221.
https://doi.org/10.1182/blood.2021012249
Published: 2022
Journal Articles

Introduction to a review series on immunotherapies for nonmalignant hematologic diseases

Clinical Trials & Observations
Catherine M. Bollard
Journal: Blood
Blood (2022) 139 (25): 3561.
https://doi.org/10.1182/blood.2022016022
Published: 2022
Journal Articles

EBV + lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic target

Keri Toner, Catherine M. Bollard
Journal: Blood
Blood (2022) 139 (7): 983–994.
https://doi.org/10.1182/blood.2020005466
Published: 2022
Journal Articles

Outcome of Donor-Derived Tumor Associated Antigen-Specific T Cell Therapy in Patients with High-Risk or Relapsed Acute Leukemia Post Allogeneic BMT

Hannah Kinoshita, Kenneth R. Cooke, Melanie Grant, Maja Stanojevic, Conrad Russell Young Cruz, Michael Keller, Maria Fernanda Fortiz, Fahmida Hoq, Haili Lang, John Barrett, Hua Liang, Jay Tanna, Nan Zhang, Abeer Shibli, Anushree Datar, Kirsten M. Williams, Hema Dave, Jeffrey Dome, David Jacobsohn, Patrick Hanley, Richard J. Jones, Catherine M. Bollard
Journal: Blood
Blood (2021) 138 (Supplement 1): 2828.
https://doi.org/10.1182/blood-2021-153207
Published: 2021
Journal Articles

Intensification of Chemotherapy Using a Modified BFM Backbone for Children, Adolescents and Young Adults with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) Identifies Highly Chemorefractory Patients Who Benefit from Allogeneic Hematopoietic Stem Cell Transplantation

Paul Harker-Murray, Brent L. Wood, Meenakshi Devidas, Zhiguo Chen, Tal Schechter-Finkelstein, Robert J. Hayashi, Keith J August, Kimberly P. Dunsmore, Michelle L. Hermiston, Terzah M. Horton, Yoav H. Messinger, Sarah L Vargas, Eric S Schafer, Maria Luisa Sulis, Stuart S. Winter, Charlotte Wood, Catherine M Bollard, Mignon L. Loh, Stephen P Hunger, Elizabeth A. Raetz, David T. Teachey
Journal: Blood
Blood (2021) 138 (Supplement 1): 3487.
https://doi.org/10.1182/blood-2021-151837
Published: 2021
Journal Articles

Peri-Transplant Alemtuzumab Levels Predict Risk of Secondary Graft Failure and Inversely Impact CXCL9 Levels after RIC HCT (A Correlative Biology Study to BMT-CTN 1204 RICHI)

Ashley V Geerlinks, Brooks Scull, Christa Krupski, Ryan Fleischmann, Michael A. Pulsipher, Mary Eapen, Jim A. Connelly, Catherine M. Bollard, Sung-Yun Pai, Christine N. Duncan, Leslie S Kean, K. Scott Baker, Lauri S Burroughs, Jeffrey R. Andolina, Michael B Jordan, Tsz-Kwong Man, Carl E. Allen, Rebecca A. Marsh
Journal: Blood
Blood (2021) 138 (Supplement 1): 748.
https://doi.org/10.1182/blood-2021-145629
Published: 2021
Journal Articles

Introduction to a review series on gene therapy and gene editing for sickle cell disease and hemophilia

Catherine M. Bollard
Journal: Blood
Blood (2021) 138 (11): 913.
https://doi.org/10.1182/blood.2021012891
Published: 2021
Journal Articles

Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK + ALCL: results of COG trial ANHL12P1

Clinical Trials & Observations
Eric J. Lowe, Anne F. Reilly, Megan S. Lim, Thomas G. Gross, Lauren Saguilig, Donald A. Barkauskas, Rui Wu, Sarah Alexander, Catherine M. Bollard
Journal: Blood
Blood (2021) 137 (26): 3595–3603.
https://doi.org/10.1182/blood.2020009806
Published: 2021
Includes: Supplemental data
Journal Articles

Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH

Amel Sengal, Jessica Velazquez, Meryl Hahne, Thomas M. Burke, Harshal Abhyankar, Robert Reyes, Walter Olea, Brooks Scull, Olive S. Eckstein, Camille Bigenwald, Catherine M. Bollard, Wendong Yu, Miriam Merad, Kenneth L. McClain, Carl E. Allen, Rikhia Chakraborty
Journal: Blood
Blood (2021) 137 (13): 1777–1791.
https://doi.org/10.1182/blood.2020005867
Published: 2021
Includes: Supplemental data